Clinical trial
Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to…
NCT00181051 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Suspended
Key facts
| NCT number | NCT00181051 |
|---|---|
| Title | Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia |
| Official title | Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Suspended |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Scheduled General Anesthesia |
| Intervention type | Device |
| Interventions | Alaris AEP monitor |
| Enrollment | 128 |
| Start date | Feb 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: